Organogenesis Ownership | Who Owns Organogenesis?


OverviewForecastRevenueFinancialsChartTranscripts

Organogenesis Ownership Summary


Organogenesis is owned by 54.63% institutional investors, 46.49% insiders. Soleus capital management is the largest institutional shareholder, holding 9.73% of ORGO shares. Xtrackers S&P 500 Swap ETF 1C is the top mutual fund, with 2.56% of its assets in Organogenesis shares.

ORGO Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockOrganogenesis54.63%46.49%-1.12%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustrySpecialty & Generic Drug Manufacturers Stocks43.51%11.55%44.95%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Soleus capital management12.34M9.73%$45.18M
Morgan stanley11.58M8.78%$32.41M
First light asset management6.78M5.34%$24.80M
Blackrock5.09M3.86%$14.24M
Blackrock funding, inc. /de4.73M3.73%$17.33M
Vanguard group3.59M2.71%$11.49M
Assenagon asset management2.86M2.25%$10.46M
Dimensional fund advisors lp2.79M2.10%$8.93M
Acadian asset management2.42M1.91%$8.86M
Deutsche bank ag\2.45M1.85%$7.84M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
First light asset management6.78M3.22%$24.80M
Soleus capital management12.34M2.99%$45.18M
Highmark wealth management293.03K0.52%$1.07M
Intrepid family office110.00K0.33%$402.60K
Wealth dimensions group407.96K0.32%$1.31M
Kent lake capital151.91K0.19%$425.33K
Ajovista15.51K0.13%$43.44K
Capital square22.50K0.05%$96.75K
Palumbo wealth management41.06K0.05%$150.28K
Skopos labs66.48K0.03%$243.33K

Top Buyers

HolderShares% AssetsChange
First light asset management6.78M3.22%6.78M
Assenagon asset management2.86M0.02%2.52M
Norges bank482.20K0.00%482.20K
Dimensional fund advisors lp2.79M0.00%442.77K
Goldman sachs group656.16K0.00%383.52K

Top Sellers

HolderShares% AssetsChange
Deutsche bank ag\2.45M0.00%-2.39M
Driehaus capital management---1.80M
Aqr capital management1.52M0.01%-1.19M
Healthcare of ontario pension plan trust fund---649.90K
Lazard asset management---649.38K

New Positions

HolderShares% AssetsChangeValue
First light asset management6.78M3.22%6.78M$24.80M
Norges bank482.20K0.00%482.20K$1.54M
Highmark wealth management293.03K0.52%293.03K$1.07M
Kent lake capital151.91K0.19%151.91K$425.33K
Hennion & walsh asset management93.41K0.01%93.41K$341.87K

Sold Out

HolderChange
Assetmark-4.00
Ifp advisors-9.00
Northwestern mutual wealth management-10.00
Nelson, van denburg & campbell wealth management group-13.00
Us bancorp \de\-33.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2025113-17.52%69,296,6277.39%542.09%50-32.43%472.17%
Mar 31, 202513613.33%64,503,6783.15%512.30%7417.46%4631.43%
Dec 31, 202443-61.61%19,203,473-69.76%140.63%19-64.15%11-71.79%
Sep 30, 2024112-4.27%63,509,8320.99%472.11%53-26.39%3930.00%
Jun 30, 2024117-6.40%62,887,60411.28%472.56%7212.50%30-31.82%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Xtrackers S&P 500 Swap ETF 1C3.25M2.56%-
Xtrackers S&P 500 2xLev Dly Swap ETF 1C2.41M1.82%-
Xtrackers S&P Global Infra Swap ETF 1C2.08M1.64%-
Vanguard Total Stock Mkt Idx Inv1.93M1.52%-42.63K
iShares Russell 2000 ETF1.67M1.32%-31.71K
Vanguard US Total Market Shares ETF1.59M1.25%-
Vanguard Institutional Extnd Mkt Idx Tr776.48K0.61%-350.98K
Heptagon Driehaus US Micro Cap Eq C$ Acc703.51K0.55%-9.64K
Fidelity Small Cap Index684.47K0.54%-10.13K
Vanguard Explorer Inv668.02K0.53%440.34K

Recent Insider Transactions


DateNameRoleActivityValue
Jun 06, 2025Freedman Lori Chief Admin. and Legal OfficerBuy$26.95K
Jun 04, 2025Freedman Lori Chief Admin. and Legal OfficerBuy$284.72K
Jun 05, 2025Freedman Lori Chief Admin. and Legal OfficerBuy$413.63K
Mar 04, 2025Driscoll Michael Joseph-Sell$127.53K
Dec 13, 2024Gillheeney Gary S. President and CEOSell$186.87K

Insider Transactions Trends


DateBuySell
2025 Q3--
2025 Q23-
2025 Q1-1
2024 Q4-7
2024 Q3--

ORGO Ownership FAQ


Who Owns Organogenesis?

Organogenesis shareholders are primarily institutional investors at 54.63%, followed by 46.49% insiders and -1.12% retail investors. The average institutional ownership in Organogenesis's industry, Specialty & Generic Drug Manufacturers Stocks, is 43.51%, which Organogenesis exceeds.

Who owns the most shares of Organogenesis?

Organogenesis’s largest shareholders are Soleus capital management (12.34M shares, 9.73%), Morgan stanley (11.58M shares, 8.78%), and First light asset management (6.78M shares, 5.34%). Together, they hold 23.85% of Organogenesis’s total shares outstanding.

Does Blackrock own Organogenesis?

Yes, BlackRock owns 3.86% of Organogenesis, totaling 5.09M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 14.24M$. In the last quarter, BlackRock increased its holdings by 112.84K shares, a 2.27% change.

Who is Organogenesis’s biggest shareholder by percentage of total assets invested?

First light asset management is Organogenesis’s biggest shareholder by percentage of total assets invested, with 3.22% of its assets in 6.78M Organogenesis shares, valued at 24.8M$.

Who is the top mutual fund holder of Organogenesis shares?

Xtrackers S&P 500 Swap ETF 1C is the top mutual fund holder of Organogenesis shares, with 2.56% of its total shares outstanding invested in 3.25M Organogenesis shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools